Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction RE Redgrave, E Dookun, LK Booth, M Camacho Encina, O Folaranmi, ... npj Aging 9 (1), 15, 2023 | 11 | 2023 |
Heart disease and ageing: the roles of senescence, mitochondria, and telomerase in cardiovascular disease LK Booth, RE Redgrave, S Tual-Chalot, I Spyridopoulos, HM Phillips, ... Biochemistry and Cell Biology of Ageing: Part IV, Clinical Science, 45-78, 2023 | 8 | 2023 |
Anthracycline-induced cardiotoxicity and senescence LK Booth, RE Redgrave, O Folaranmi, JH Gill, GD Richardson Frontiers in aging 3, 1058435, 2022 | 5 | 2022 |
Cellular Senescence, Mitochondrial Dysfunction, and Their Link to Cardiovascular Disease M Camacho-Encina, LK Booth, RE Redgrave, O Folaranmi, ... Cells 13 (4), 353, 2024 | 3 | 2024 |
Author correction: senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction RE Redgrave, E Dookun, LK Booth, MC Encina, O Folaranmi, ... npj Aging 9 (1), 2023 | 3 | 2023 |
Suppressed basal mitophagy drives cellular aging phenotypes that can be reversed by a p62-targeting small molecule G Kelly, T Kataura, J Panek, G Ma, H Salmonowicz, A Davis, H Kendall, ... Dev Cell 59 (10.1016), 2024 | 1 | 2024 |
BS5 Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction R Redgrave, E Dookun, L Booth, O Folaranmi, S Tual-Chalot, J Gill, ... Heart 109 (Suppl 3), A249-A249, 2023 | | 2023 |
BS31 The senescence-associated secretory phenotype as a biomarker for age-related myocardial remodelling and cardiovascular disease L Booth, R Redgrave, MC Encina, S Tual-Chalot, O Folaranmi, ... Heart 109 (Suppl 3), A265-A266, 2023 | | 2023 |
BS58 Identifying older donor hearts suitable for transplantation: the use of senescence as a marker of biological age. MC Encina, A Tyler, I Hardwick, L Booth, R Redgrave, G Richardson Heart 109 (Suppl 3), A288-A289, 2023 | | 2023 |